Fundraising Fox
Soteria Biotherapeutics, Inc.
San Francisco, US · Founded 2018 · 6 known investors
Find your way into Soteria Biotherapeutics, Inc.
Sign up to see every warm intro you have to Soteria Biotherapeutics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Soteria Biotherapeutics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.
Founders & leadership
Soteria Biotherapeutics, Inc. was founded in 2018 by Jim Wells.
Board
Investors · 6
How we know: the company's own site · funding news · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · funding news · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$24.9M disclosed across 1 round · 2021
▶$24.9MraisedMay 2021 · 8 investors · BiotechnologyRule 506(b)
- Nisha MaratheDirector
- Kristine M BallExecutive Officer, Director
- David AllisonDirector
- Keno GutierrezDirector
- David MorrisDirector
- Steve JamesDirector
- Momo WuDirector
- Zachary HillExecutive Officer, Director
- Offering amount
- $42.2M
- Amount sold
- $24.9M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Soteria Biotherapeutics, Inc. went on to found or lead other companies.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $299.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Soteria Biotherapeutics, Inc. do?
- Soteria Biotherapeutics develops protein-based biotherapeutics and small molecules using its LITE Switch technology platform for drug discovery and development across oncology, immune-oncology, and inflammatory disease indications.
- Who founded Soteria Biotherapeutics, Inc.?
- Soteria Biotherapeutics, Inc. was founded by Jim Wells in 2018.
- Who are Soteria Biotherapeutics, Inc.'s investors?
- Soteria Biotherapeutics, Inc.'s investors include 5AM Ventures, Novartis Venture Fund, Roche Venture Fund, Versant Ventures, BioGeneration Ventures, Westlake Village BioPartners.
- How much funding has Soteria Biotherapeutics, Inc. raised?
- Soteria Biotherapeutics, Inc. has disclosed $24.9M raised across 1 round.
- Where is Soteria Biotherapeutics, Inc. headquartered?
- Soteria Biotherapeutics, Inc. is headquartered in San Francisco, US.